litlas
Log inCreate account

John Bradley

Active 1966–2026

166
Papers
20,757
Citations
68
h-index
143
i10-index

Citations

Citations per year for John Bradley1933: 1 citations1961: 1 citations1966: 19 citations1967: 1 citations1971: 2 citations1973: 1 citations1975: 2 citations1976: 2 citations1978: 1 citations1986: 2 citations1987: 1 citations1988: 3 citations1989: 1 citations1990: 8 citations1991: 15 citations1992: 14 citations1993: 13 citations1994: 31 citations1995: 25 citations1996: 32 citations1997: 26 citations1998: 20 citations1999: 26 citations2000: 26 citations2001: 35 citations2002: 21 citations2003: 33 citations2004: 39 citations2005: 28 citations2006: 46 citations2007: 61 citations2008: 68 citations2009: 57 citations2010: 90 citations2011: 78 citations2012: 81 citations2013: 144 citations2014: 155 citations2015: 232 citations2016: 223 citations2017: 262 citations2018: 240 citations2019: 708 citations2020: 799 citations2021: 788 citations2022: 629 citations2023: 507 citations2024: 794 citations2025: 417 citations2026: 42 citations1934–1960: no citations, so these years are not shown1962–1965: no citations, so these years are not shown1968–1970: no citations, so these years are not shown1972: no citations, so this year is not shown1974: no citations, so this year is not shown1977: no citations, so this year is not shown1979–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,270 citing papers, 23.3% of this breakdownUnited Kingdom: 982 citing papers, 10.1% of this breakdownChina: 609 citing papers, 6.2% of this breakdownGermany: 390 citing papers, 4% of this breakdownFrance: 382 citing papers, 3.9% of this breakdownCanada: 322 citing papers, 3.3% of this breakdownAustralia: 309 citing papers, 3.2% of this breakdownNetherlands: 293 citing papers, 3% of this breakdownItaly: 291 citing papers, 3% of this breakdownSwitzerland: 244 citing papers, 2.5% of this breakdownJapan: 239 citing papers, 2.5% of this breakdownSpain: 226 citing papers, 2.3% of this breakdown
0%23.3%Other 32.7%

Institutions

Fields

  • Medicine60.8%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Immunology and Microbiology9.7%
  • Computer Science7.3%
  • Social Sciences2.8%
  • Engineering1.2%
  • Other7.1%

Topics

  • Malaria Research and Control4.4%
  • Rheumatoid Arthritis Research and Therapies4.2%
  • Mosquito-borne diseases and control3.5%
  • Osteoarthritis Treatment and Mechanisms2.6%
  • T-cell and B-cell Immunology2.4%
  • Immune Cell Function and Interaction2.4%
  • Other80.5%

Coauthors

All papers

Open in search
  1. JSON Web Token (JWT)

    Authors: Michael B. Jones, John Bradley, Nat Sakimura - RFC 2015 cited by 370

  2. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

    Authors: Mehreen S. Datoo, Alassane Dicko, Halidou Tinto, Jean‐Bosco Ouédraogo, Mainga Hamaluba, Ally Olotu, Emma Beaumont, Fernando Ramos Lopez, Hamtandi Magloire Natama, Sophie Weston, Mwajuma Chemba, Yves Daniel Compaoré, Djibrilla Issiaka, Diallo Salou, Athanase M Some, Sharon Omenda, Alison M. Lawrie, Philip Bejon, Harish Rao, Daniel Chandramohan, Rachel Roberts, Sandesh Bharati, Lisa Stockdale, Sunil Gairola, Brian Greenwood, Katie Ewer, John Bradley, Prasad S. Kulkarni, Umesh Shaligram, Adrian V. S. Hill, Almahamoudou Mahamar, Koualy Sanogo, Youssoufa Sidibé, Kalifa Diarra, Mamoudou Samassekou, Oumar Attaher, Amadou Tapily, Makonon Diallo, Oumar M Dicko, Mahamadou Kaya, Seydina O Maguiraga, Yaya Sankaré, Hama Yalcouye, Soumaïla Diarra, Sidi M. Niambele, Ismaila Théra, Issaka Sagara, Mala Sylla, Amagana Dolo, Nsajigwa Misidai, Sylvester Simando, Hania Msami, Omary Juma, Nicolaus Gutapaka, Rose Paul, Sarah Mswata, Ibrahim Sasamalo, Kasmir Johaness, Mwantumu Sultan, Annastazia Alexander, Isaac Kimaro, Kauye Lwanga, Mwajuma Mtungwe, Kassim Khamis, Lighton Rugarabam, Wilmina F. Kalinga, Mohammed Mohammed, Janeth Kamange, Jubilate Msangi, Batuli Mwaijande, Ivanny M. Mtaka, Matilda Mhapa, Tarsis Mlaganile, Thabit Mbaga, Rakiswendé Serge Yerbanga, Wendkouni Samtouma, Abdoul Aziz Sienou, Zachari Kabré, Wendinpui Jedida Muriel Ouedraogo, G. Armel Bienvenu Yarbanga, Issaka Zongo, Hamade Savadogo, Joseph Sanon, Judicael Compaore, Idrissa Kere, Ferdinand Lionel Yoni, Tewende Martine Sanre, Seydou Bienvenu Ouattara, Samuel Provstgaard-Morys, Danielle Woods, Robert W. Snow, Amek Nyaguara, Caroline Ngetsa, Lynette Isabella Ochola‐Oyier, Jennifer Musyoki, Marianne Munene, Noni Mumba, Uche J. Adetifa, Charles Muiruri, Jimmy Shangala Mwawaka and 19 more - The Lancet 2024 cited by 351

  3. The establishment of resident memory B cells in the lung requires local antigen encounter

    Authors: S. Rameeza Allie, John Bradley, Uma Mudunuru, Michael D. Schultz, Beth Graf, Frances E. Lund, Troy D. Randall - Nature Immunology 2018 cited by 399

  4. Tofacitinib versus Methotrexate in Rheumatoid Arthritis

    Authors: Eun Bong Lee, Roy Fleischmann, Stephen Hall, Bethanie Wilkinson, John Bradley, David Gruben, Tamás Koncz, Sriram Krishnaswami, Gene V. Wallenstein, Chuanbo Zang, Samuel H. Zwillich, Ronald van Vollenhoven - New England Journal of Medicine 2014 cited by 774

  5. Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

    Authors: Roy Fleischmann, Joel M. Kremer, John J. Cush, Hendrik Schulze‐Koops, Carol A. Connell, John Bradley, David Gruben, Gene V. Wallenstein, Samuel H. Zwillich, Keith S. Kanik - New England Journal of Medicine 2012 cited by 1,030

  6. The journal of clinical investigation

    Authors: G. Nicholas Rogentine, T David S. Rowe, John Bradley, Thomas A, John, L. Fahey - Journal of the American Dietetic Association 1994 cited by 1,203

  7. Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

    Authors: Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen, Eun Bong Lee, Juan A. García Meijide, Sylke Wagner, Šárka Forejtová, Samuel H. Zwillich, David Gruben, Tamás Koncz, Gene V. Wallenstein, Sriram Krishnaswami, John Bradley, Bethanie Wilkinson - New England Journal of Medicine 2012 cited by 939

  8. Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer

    Authors: Lawrence B. Snyder, John J. Flanagan, Yimin Qian, Sheryl M. Gough, Monica Andreoli, Mark Bookbinder, Gregory Cadelina, John Bradley, Emma Rousseau, Julian Chandler, Ryan R. Willard, Jennifer Pizzano, Craig M. Crews, Andrew P. Crew, John Houston, Marcia Dougan Moore, R. Peck, I Taylor - Cancer Research 2021 cited by 110

  9. Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis

    Authors: Daniel O. Clegg, Domenic J. Reda, Crystal L. Harris, Marguerite Klein, James R. O’Dell, Michele Hooper, John Bradley, Clifton O. Bingham, Michael H. Weisman, Christopher G. Jackson, Nancy E. Lane, John J. Cush, Larry W. Moreland, H. Ralph Schumacher, Chester V. Oddis, Frederick Wolfe, Jerry A. Molitor, David E. Yocum, Thomas J. Schnitzer, Daniel E. Furst, Allen D. Sawitzke, Helen Shi, Kenneth D. Brandt, Roland W. Moskowitz, H. James Williams - New England Journal of Medicine 2006 cited by 1,327

  10. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

    Authors: Síle F. Molloy, Cecilia Kanyama, Robert S. Heyderman, Angela Loyse, Charles Kouanfack, Duncan Chanda, Sayoki Mfinanga, Elvis Temfack, Shabir Lakhi, Sokoine Lesikari, Adrienne K Chan, Neil Stone, Newton Kalata, Natasha Karunaharan, Kate Gaskell, Mary Peirse, Jayne Ellis, Chimwemwe Chawinga, Sandrine Sa’a Lontsi, Jean-Gilbert Ndong, Philip Bright, Duncan Lupiya, Tao Chen, John Bradley, Jack Adams, Charles van der Horst, Joep J. van Oosterhout, Victor Sini, Yacouba Njankouo Mapoure, Peter Mwaba, Tihana Bicanic, David G. Lalloo, Duolao Wang, Mina C. Hosseinipour, Olivier Lortholary, Shabbar Jaffar, Thomas S. Harrison - New England Journal of Medicine 2018 cited by 405

  11. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

    Authors: Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman, J. Wollenhaupt, Cristiano A. F. Zerbini, Birgitta Benda, David Gruben, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, Tamás Koncz, Koshika Soma, John Bradley, Charles A. Mebus - The Lancet 2013 cited by 720

  12. Large-scale field trial of attractive toxic sugar baits (ATSB) for the control of malaria vector mosquitoes in Mali, West Africa

    Authors: Mohamad M. Traore, Amy Junnila, Sékou F. Traorè, Seydou Doumbia, Edita E. Revay, Vasiliy D. Kravchenko, Yosef Schlein, Kristopher L. Arheart, Petrányi Gergely, Rui-De Xue, Axel Hausmann, Robert Beck, Alex M. Prozorov, Rabiatou A. Diarra, Aboubakr S. Kone, Silas Majambere, John Bradley, John Vontas, John C. Beier, Günter C. Müller - Malaria Journal 2020 cited by 142

  13. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor

    Authors: Xingyue He, Jessica Riceberg, Teresa A. Soucy, Erik Koenig, James Minissale, Melissa Gallery, Hugues Bernard, Xiaofeng Yang, Hua Liao, Claudia Rabino, Pooja Shah, Kristina Xega, Zhonghua Yan, Mike Sintchak, John Bradley, He N. Xu, Matt O. Duffey, Dylan B. England, Hirotake Mizutani, Zhigen Hu, Jianping Guo, Ryan Chau, Lawrence R. Dick, James E. Brownell, John Newcomb, Steven Langston, Eric S. Lightcap, Neil Bence, Sai Murali Krishna Pulukuri - Nature Chemical Biology 2017 cited by 229

  14. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation

    Authors: Esther Zumaquero, Sara L. Stone, Christopher D. Scharer, Scott A. Jenks, Anoma Nellore, Betty Mousseau, Antonio Rosal‐Vela, Davide Botta, John Bradley, Wojciech Wojciechowski, Travis Ptacek, Maria I. Danila, Jeffrey C. Edberg, S. Louis Bridges, Robert P. Kimberly, Winn Chatham, Trenton R. Schoeb, Alexander F. Rosenberg, Jeremy M. Boss, Igñacio Sanz, Frances E. Lund - eLife 2019 cited by 181

  15. A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans

    Authors: Anoma Nellore, Esther Zumaquero, Christopher D. Scharer, Christopher Fucile, Christopher M. Tipton, R. Glenn King, Mi Tian, Betty Mousseau, John Bradley, Fen Zhou, Stuti Mutneja, Paul A. Goepfert, Jeremy M. Boss, Troy D. Randall, Igñacio Sanz, Alexander F. Rosenberg, Frances E. Lund - Immunity 2023 cited by 84

  16. JSON Web Signature (JWS)

    Authors: Michael B. Jones, John Bradley, Nat Sakimura - RFC 2015 cited by 103

  17. Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis

    Authors: Joel M. Kremer, Zhanguo Li, Stephen Hall, Roy Fleischmann, Mark C. Genovese, E. Martín‐Mola, John D. Isaacs, David Gruben, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, Tamás Koncz, Richard J. Riese, John Bradley - Annals of Internal Medicine 2013 cited by 447

  18. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity

    Authors: Bronner P. Gonçalves, Melissa C. Kapulu, Patrick Sawa, Wamdaogo M. Guelbéogo, Alfred B. Tiono, Lynn Grignard, William J. Stone, Joel Hellewell, Kjerstin Lanke, Guido J. H. Bastiaens, John Bradley, Issa Nébié, Joyce Ngoi, Robin Oriango, Dora Mkabili, Maureen Nyaurah, Janet Midega, Dyann F. Wirth, Kevin Marsh, Thomas S. Churcher, Philip Bejon, Sodiomon B. Sirima, Chris Drakeley, Teun Bousema - Nature Communications 2017 cited by 261

  19. Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection

    Authors: Davide Botta, Michael J. Fuller, Tatiana T. Marquez‐Lago, Holly Bachus, John Bradley, Amy S. Weinmann, Allan Zajac, Troy D. Randall, Frances E. Lund, Beatriz León, André Ballesteros‐Tato - Nature Immunology 2017 cited by 226

  20. Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

    Authors: Désirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, Edward Keystone, Joel M. Kremer, Cristiano A. F. Zerbini, Myrna Cardiel, Stanley Cohen, Peter Nash, Yeong Wook Song, Dana Tegzová, Bradley T. Wyman, David Gruben, Birgitta Benda, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, John Bradley, Carol A. Connell, and the ORAL Scan Investigators - Arthritis & Rheumatism 2013 cited by 582

  21. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

    Authors: D L Boyle, K. Soma, J Hodge, Arthur Kavanaugh, David R. Mandel, Philip J. Mease, R Shurmur, Ash Singhal, Nathan Wei, Sanna Rosengren, Irina V Kaplan, S. Krishnaswami, Zhen Luo, John Bradley, Gary S. Firestein - Annals of the Rheumatic Diseases 2014 cited by 298

  22. Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

    Authors: Joseph N Jarvis, Tihana Bicanic, Angela Loyse, Daniel Namarika, Arthur Jackson, Jesse C. Nussbaum, Nicky Longley, Conrad Muzoora, Jacob Phulusa, Kabanda Taseera, Creto Kanyembe, Douglas Wilson, Mina C. Hosseinipour, Annemarie E. Brouwer, Direk Limmathurotsakul, Nicholas J. White, Charles van der Horst, Robin Wood, Graeme Meintjes, John Bradley, Shabbar Jaffar, Thomas S. Harrison - Clinical Infectious Diseases 2013 cited by 371

  23. Attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia

    Authors: Attractive Targeted Sugar Bait Phase III Trial Group, Thomas P. Eisele, Immo Kleinschmidt, Sophie Sarrassat, Feiko O. ter Kuile, John M. Miller, Javan Chanda, Kafula Silumbe, Aaron M. Samuels, Julia Janssen, Caroline Ogwang, John Bradley, Erica Orange, Joshua Yukich, Ruth A. Ashton, Irene Kyomuhangi, Angela F. Harris, Seydou Doumbia, Mahamoudou Touré, Mohamed Moumine, Silas Majambere, Monicah M. Mburu, Gift Mwaanga, Limonty Simubali, Edgar Simulundu, Adam Bennett, Laurence Slutsker, Günter C. Müller, Eric Ochomo, John E. Gimnig, P. Johnson, Joseph Wagman, Megan Littrell - Trials 2022 cited by 72

  24. Implications of insecticide resistance for malaria vector control with long-lasting insecticidal nets: a WHO-coordinated, prospective, international, observational cohort study

    Authors: Immo Kleinschmidt, John Bradley, Tessa Knox, Abraham Mnzava, Hmooda Toto Kafy, Charles Mbogo, Bashir Adam Ismail, Jude D. Bigoga, Alioun Adéchoubou, Kamaraju Raghavendra, Jackie Cook, Elfatih M Malik, Zinga José Nkuni, Michael B. MacDonald, Nabie Bayoh, Eric Ochomo, Étienne Fondjo, Herman Parfait Awono-Ambene, Josiane Etang, Martin Akogbéto, R M Bhatt, Mehul Kumar Chourasia, Dipak Kumar Swain, Teresa Kinyari, Krishanthi Subramaniam, Achille Massougbodji, Mariam Okê-Sopoh, Aurore Ogouyèmi-Hounto, Célestin Kouambeng, Mujahid Sheikhedin Abdin, Philippa West, Khalid A Elmardi, Sylvie Cornélie, Vincent Corbel, Neena Valecha, Evan Mathenge, Luna Kamau, Jo Lines, Martin J. Donnelly - The Lancet Infectious Diseases 2018 cited by 359